Secondarily, decreased phagocytosis impedes anti-tumor adaptive immunity by inhibiting antigen presentation and anti-tumor T cell priming by SIRPα-expressing dendritic cells, microglial cells, and tumor-associated macrophages [39–44]. Here, SIRPA is linked to neoplasm.